Tema Oncology ETF (NASDAQ:CANC) Sees Significant Increase in Short Interest

Tema Oncology ETF (NASDAQ:CANC) was the recipient of a significant growth in short interest in June. As of June 30th, there was short interest totaling 27,461 shares, a growth of 79.6% from the June 15th total of 15,293 shares. Based on an average daily trading volume, of 67,600 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.6% of the company’s stock are sold short.

Institutional Trading of Tema Oncology ETF

Several institutional investors have recently added to or reduced their stakes in CANC. Thrivent Financial for Lutherans raised its position in shares of Tema Oncology ETF by 891.1% during the 4th quarter. Thrivent Financial for Lutherans now owns 1,461,649 shares of the company’s stock worth $50,747,000 after purchasing an additional 1,314,177 shares during the period. Jane Street Group LLC acquired a new position in Tema Oncology ETF during the 4th quarter valued at approximately $1,100,000. Flow Traders U.S. LLC acquired a new position in Tema Oncology ETF during the 3rd quarter valued at approximately $630,000. Roxbury Financial LLC grew its stake in Tema Oncology ETF by 326.4% during the 2nd quarter. Roxbury Financial LLC now owns 3,940 shares of the company’s stock worth $162,000 after buying an additional 3,016 shares during the last quarter. Finally, LPL Financial LLC bought a new position in Tema Oncology ETF during the 4th quarter worth $278,000.

Tema Oncology ETF Trading Up 1.4%

Shares of CANC opened at $41.07 on Friday. The firm has a market cap of $194.67 million, a price-to-earnings ratio of 20.39 and a beta of 0.67. The stock has a 50 day moving average of $38.77 and a 200-day moving average of $37.47. Tema Oncology ETF has a 52 week low of $25.12 and a 52 week high of $42.63.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.